KMT2A and acute myeloid leukemia: However, this strategy can be applied to basically all existent AML mouse models, such as models driven by rearranged MLL or the cytoplasmic mutant of the nucleophosmin [21,22], to better comprehend the complex biology of this heterogeneous disease.